Tharimmune, Inc. THAR
THAR
Tharimmune, Inc.
SNSE
Sensei Biotherapeutics, Inc.
ATHA
Athira Pharma, Inc.
GOVX
GeoVax Labs, Inc.
CTXR
Citius Pharmaceuticals, Inc.
IBIO
iBio, Inc.
PALI
Palisade Bio, Inc.
INTS
Intensity Therapeutics, Inc.
CLRB
Cellectar Biosciences, Inc.
MBRX
Moleculin Biotech, Inc.
| Periode |
THAR |
SNSE |
ATHA |
GOVX |
CTXR |
IBIO |
PALI |
INTS |
CLRB |
MBRX |
| 6M
| 154.87 % |
116.71 % |
53.14 % |
-32.24 % |
52.89 % |
-5.00 % |
140.31 % |
-85.79 % |
-47.05 % |
-44.86 % |
| YTD
| 40.49 % |
70.63 % |
-33.45 % |
-77.33 % |
-61.86 % |
-65.06 % |
-6.99 % |
-84.98 % |
-51.28 % |
-72.75 % |
| 1Y
| 22.55 % |
107.50 % |
-18.30 % |
-72.03 % |
-85.56 % |
-70.33 % |
-51.54 % |
-91.79 % |
-92.31 % |
-79.56 % |
| 3Y
| -98.84 % |
-39.81 % |
-89.54 % |
-95.59 % |
-94.76 % |
-98.20 % |
-97.69 % |
-95.59 % |
-92.53 % |
-96.75 % |
| 5Y
| -99.78 % |
-95.35 % |
-98.25 % |
-98.85 % |
-95.07 % |
-99.91 % |
-99.94 % |
-95.59 % |
-98.72 % |
-99.34 % |
| 10Y
| -99.78 % |
-95.35 % |
-97.86 % |
-98.73 % |
-99.70 % |
-99.98 % |
-100.00 % |
-95.59 % |
-99.99 % |
-99.93 % |
| From the beginning
| -99.78 % |
-95.35 % |
-97.86 % |
-98.73 % |
-99.61 % |
-99.98 % |
-100.00 % |
-95.59 % |
-100.00 % |
-99.93 % |